BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24722758)

  • 21. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
    Liu S; Tetzlaff MT; Cui R; Xu X
    Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.
    Bhattacharya A; Schmitz U; Wolkenhauer O; Schönherr M; Raatz Y; Kunz M
    Oncogene; 2013 Jun; 32(26):3175-83. PubMed ID: 22847610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma.
    Sun YW; Li XH; Wang H; Wu J
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3876-3884. PubMed ID: 31115015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA miR-125b induces senescence in human melanoma cells.
    Glud M; Manfé V; Biskup E; Holst L; Dirksen AM; Hastrup N; Nielsen FC; Drzewiecki KT; Gniadecki R
    Melanoma Res; 2011 Jun; 21(3):253-6. PubMed ID: 21460750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin.
    Li N; Liu Y; Pang H; Lee D; Zhou Y; Xiao Z
    Med Sci Monit; 2019 Mar; 25():1590-1599. PubMed ID: 30821276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA SNHG7 promotes malignant melanoma progression through negative modulation of miR-9.
    Wang W; Liu G; Liu M; Li X
    Histol Histopathol; 2020 Sep; 35(9):973-981. PubMed ID: 32365219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-153-3p suppress cell proliferation and invasion by targeting SNAI1 in melanoma.
    Zeng HF; Yan S; Wu SF
    Biochem Biophys Res Commun; 2017 May; 487(1):140-145. PubMed ID: 28400282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma.
    Zhou WJ; Wang HY; Zhang J; Dai HY; Yao ZX; Zheng Z; Meng-Yan S; Wu K
    Aging (Albany NY); 2020 Nov; 12(22):22759-22775. PubMed ID: 33202380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Noncoding RNA PVT1 Promotes Melanoma Progression via Endogenous Sponging miR-26b.
    Wang BJ; Ding HW; Ma GA
    Oncol Res; 2018 Jun; 26(5):675-681. PubMed ID: 28409552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial-mesenchymal transition by targetting PMEL through the Wnt signaling pathway.
    Wang JJ; Li ZF; Li XJ; Han Z; Zhang L; Liu ZJ
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28724603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma.
    Bustos MA; Ono S; Marzese DM; Oyama T; Iida Y; Cheung G; Nelson N; Hsu SC; Yu Q; Hoon DSB
    J Invest Dermatol; 2017 Sep; 137(9):1955-1964. PubMed ID: 28526299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of miR-493 promoted melanoma proliferation by suppressing IRS4 expression.
    Cui A; Jin Z; Gao Z; Jin M; Zhu L; Li L; Jin C; An Y
    Tumour Biol; 2017 May; 39(5):1010428317701640. PubMed ID: 28475006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-186 inhibits cell proliferation and invasion in human cutaneous malignant melanoma.
    Su BB; Zhou SW; Gan CB; Zhang XN
    J Cancer Res Ther; 2018; 14(Supplement):S60-S64. PubMed ID: 29578151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD).
    Reuland SN; Smith SM; Bemis LT; Goldstein NB; Almeida AR; Partyka KA; Marquez VE; Zhang Q; Norris DA; Shellman YG
    J Invest Dermatol; 2013 May; 133(5):1286-93. PubMed ID: 23190898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-603 Promotes Progression of Cutaneous Melanoma by Regulating TBX5.
    Dong X; Wang Y; Qu Y; Liu J; Feng X; Xu X
    Comput Math Methods Med; 2021; 2021():1888501. PubMed ID: 35003317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-137 inhibits proliferation of melanoma cells by targeting PAK2.
    Hao S; Luo C; Abukiwan A; Wang G; He J; Huang L; Weber CE; Lv N; Xiao X; Eichmüller SB; He D
    Exp Dermatol; 2015 Dec; 24(12):947-52. PubMed ID: 26186482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1.
    Cohen R; Greenberg E; Nemlich Y; Schachter J; Markel G
    Oncotarget; 2015 Aug; 6(22):19006-16. PubMed ID: 26158900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.